ReviewFrontiers in cellular and infection microbiology2026
Immune evasion of multidrug-resistant bacteria: insights from lung innate immune cells and targeted therapies.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pneumonia is a common acute infectious disease affecting the lower respiratory tract. Innate immune cells within the lungs play a crucial role in the onset and progression of pneumonia. Various multidrug-resistant bacteria have evolved multiple strategies to evade innate immunity, posing significant challenges to the treatment of pneumonia. This review primarily explores the major innate immune cells in the lungs and their functions, the immune evasion mechanisms of common multidrug-resistant bacteria, and the latest research advances in targeted innate immunity-based anti-infective therapies. This review synthesizes recent advances in the interaction between the innate immune system of the lungs and multidrug-resistant bacteria. It systematically categorizes and compares the immune evasion mechanisms of multidrug-resistant bacteria across four core pathways. This aims to provide novel insights for treating pulmonary infections caused by these multidrug-resistant pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.